Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Guidi

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2023
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapyPerrine Courlet, Daniel Abler, Monia Guidi, et al.
British Journal of Clinical Pharmacology|March 13, 2020
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milkEtienne Weisskopf, Monia Guidi, Céline J Fischer, et al.
British Journal of Clinical Pharmacology|July 20, 2024
A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION projectAnaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Pharmaceutics|August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Frontiers in Pharmacology|December 2, 2024
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
The Lancet Regional Health. Europe|January 1, 2024
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2023
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapyPerrine Courlet, Daniel Abler, Monia Guidi, et al.
British Journal of Clinical Pharmacology|March 13, 2020
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milkEtienne Weisskopf, Monia Guidi, Céline J Fischer, et al.
British Journal of Clinical Pharmacology|July 20, 2024
A population pharmacokinetic model for sertraline in women during the perinatal period-A contribution from the ConcePTION projectAnaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Pharmaceutics|August 26, 2022
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Frontiers in Pharmacology|December 2, 2024
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Clinical Pharmacology and Therapeutics|March 23, 2024
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIVPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
The Lancet Regional Health. Europe|January 1, 2024
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in SwitzerlandPaul Thoueille, Susana Alves Saldanha, Fabian Schaller, et al.
Pageof 11